SEC 13F Intelligence

Managers / Q2 2022 · view latest →

Lion Point Capital, LP

CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200

Reported Value
$878M
Q2 2022
Positions
40
Filings on Record
31
2019–present window
Filed
Aug 15, 2022
original filing

Summary

Lion Point Capital, LP reported $878M in U.S.-listed holdings across 40 positions for Q2 2022.

Its largest position, CHRD, represents 3.9% of the portfolio.

Compared with Q1 2022, the fund opened 9 new positions and exited 3.

Portfolio Metrics

Turnover
+26.8%
vs prior filed quarter
Top-10 Concentration
+21.8%
share of reported value
Largest Position
+3.9%
Oasis Petroleum
New / Exited
9 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $636MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.0BQ3 ’19: $897MQ4 ’19: $1.1BQ4 ’19Q1 ’20: $379MQ2 ’20: $412MQ3 ’20: $456MQ4 ’20: $519MQ4 ’20Q1 ’21: $550MQ2 ’21: $579MQ3 ’21: $533MQ4 ’21: $373MQ4 ’21Q1 ’22: $431MQ2 ’22: $878MQ3 ’22: $454MQ4 ’22: $703MQ4 ’22Q1 ’23: $243MQ2 ’23: $221MQ3 ’23: $224MQ4 ’23: $200MQ4 ’23Q1 ’24: $179MQ2 ’24: $55MQ3 ’24: $45MQ4 ’24: $19MQ4 ’24Q1 ’25: $16MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $19MQ4 ’25Q1 ’26: $17Mfilingsflow.com

Portfolio Composition

By security type
ETP: 60.7%Common Stock: 35.0%Other: 3.8%US DOMESTIC: 0.4%
  • ETP · 60.7% · $533M
  • Common Stock · 35.0% · $308M
  • Other · 3.8% · $34M
  • US DOMESTIC · 0.4% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+1.53M1.53M+$259M$259M
VANECK ETF TRUSTNEW+850.0K850.0K+$173M$173M
SPDR S&P 500 ETF TRUSTNEW+228.5K228.5K+$86M$86M
EXECHESAPEAKE ENERGY CORPNEW+299.3K299.3K+$28M$28M
IM8NINSMED INCNEW+397.2K397.2K+$8M$8M
OVVOVINTIV INCNEW+90.0K90.0K+$5M$5M
AAPLAPPLE INCNEW+35.0K35.0K+$5M$5M
APTIV PLCNEW+40.0K40.0K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

31 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CHRDOASIS PETROLEUM INChistory →COM NEW3.91%$34M237.5K
2EXECHESAPEAKE ENERGY CORPhistory →COM3.14%$28M299.3K
3WTWISDOMTREE INVTS INChistory →COM3.02%$27M4.52M
4OPTUALTICE USA INChistory →CL A2.23%$20M2.00M
5MARINUS PHARMACEUTICALS INCCOM NEW2.16%$19M3.68M
60LSBURGERFI INTERNATIONAL INChistory →COM2.01%$18M2.75M
7CTIC1USDCTI BIOPHARMA CORPhistory →COM1.65%$14M5.49M
81T7TRICIDA INChistory →COM1.37%$12M1.83M
9RENEW ENERGY GLOBAL PLCCL A SHS1.14%$10M1.00M
10CIVICIVITAS RESOURCES INChistory →COM NEW1.14%$10M165.0K
11PDCEUSDPDC ENERGY INChistory →COM1.02%$9M130.4K
12SWCHFSIERRA WIRELESS INCCOM0.91%$8M1.11M
13ARCONIC CORPCOM0.90%$8M837.4K
14IM8NINSMED INCCOM PAR $.010.87%$8M397.2K
15DRRXEURDURECT CORPCOM0.83%$7M13.03M
16OPHTEURIVERIC BIO INCCOM0.75%$7M706.2K
17ERFGBPENERPLUS CORPCOM0.67%$6M575.0K
18VASCULAR BIOGENICS LTDCOM0.65%$6M2.59M
19MISTMILESTONE PHARMACEUTICALS INCCOM0.64%$6M948.6K
20OVVOVINTIV INCCOM0.62%$5M90.0K
21KINIKSA PHARMACEUTICALS LTDCOM CL A0.59%$5M480.0K
22INNOVIZ TECHNOLOGIES LTDSHS0.46%$4M400.0K
23BATLBATTALION OIL CORPCOM0.44%$4M352.9K
24IQIYI INCNOTE 4.000%12/10.38%$3M4.00M
25MCRB1EURSERES THERAPEUTICS INCCOM0.30%$3M481.8K
26AGLEUSDAEGLEA BIOTHERAPEUTICS INCCOM0.16%$1M300.0K
27IMARA INCCOM0.13%$1M834.8K
28ORIGIN MATERIALS INCCOM0.11%$1M100.0K
29LUMOS PHARMA INCCOM0.08%$732,00051.2K
30SDIGSTRONGHOLD DIGITAL MINING INCLASS A COM0.04%$380,00020.0K
31SCOR1EURCOMSCORE INCCOM0.00%$25,0001.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$17M35May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$19M39Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$18M27Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$15M19Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M21May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$45M25Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$55M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$179M32May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$200M30Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$224M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$221M30Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$243M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$703M32Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$454M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$878M40Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$431M35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$373M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$533M38Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$579M34Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M30May 19, 2021RESTATEMENTchanges · EDGAR ↗
Q4 2020$519M24Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$456M24Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$412M24Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$379M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B26Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$897M26Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.0B24Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B24May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$636M35Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.